Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection
Clinical trial NCT04412863 · COMPLETED
Trial details
- NCT number
- NCT04412863
- Sponsor
- Vir Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-03
- Primary completion
- 2024-03-25
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.